Literature DB >> 24678121

Comparison of dexmedetomidine and midazolam for monitored anesthesia care combined with tramadol via patient-controlled analgesia in endoscopic nasal surgery: A prospective, randomized, double-blind, clinical study.

Kazim Karaaslan1, Fahrettin Yilmaz2, Nebahat Gulcu1, Cemil Colak3, Murat Sereflican2, Hasan Kocoglu1.   

Abstract

UNLABELLED: Abstract.
BACKGROUND: Monitored anesthesia care (MAC) may be applied for septoplasty or endoscopic sinus surgery in which an adequate sedation and analgesia without respiratory depression are desired for comfort of both the patient and the surgeon. Several combinations with different agents have been used for this purpose in these patients. However, analgesic properties for these agents have not been reported.
OBJECTIVE: The aim of this study was to investigate the analgesic and sedative effects of dexmedetomidine or midazolam infusion combined with tramadol that was used via patient-controlled analgesia (PCA), and to document the effects of these drugs on early cognitive functions.
METHODS: This prospective, randomized, double-blind, clinical study enrolled patients undergoing septoplasty or endoscopic sinus surgery at the Abant Izzet Baysal University Hospital, Bolu, Turkey, between February and September 2006. Patients were randomly allocated in a 1:1 ratio into 1 of 2 groups: the dexmedetomidine group (group D) patients received IV dexmedetomidine 1 μg/kg for 10 minutes followed by continuous infusion of 0.5 μg/kg · h(-1); and the midazolam group (group M) patients were administered a loading dose of IV midazolam 40 μg/kg for 10 minutes followed by infusion at the rate of 50 μg/kg · h(-1). A 1-minute bolus dose of IV tramadol (1.5 mg/kg) was administered in both groups 10 minutes after the administration of the primary drug, and continued via infusion using a PCA device. After baseline measurements, systolic arterial pressure (SAP), diastolic arterial pressure (DAP), mean arterial pressure (MAP), heart rate (HR), oxygen saturation, and rate of respiration were recorded after the loading dose of study drug, after the bolus tramadol dose, at 10-minute intervals during the operation, and twice in the recovery rooms; 5 minutes after arrival and 5 minutes before discharge. Verbal rating score (VRS) and Ramsay sedation score were determined at baseline (after surgery was started), every 10 minutes thereafter until the end of the operation, and 2 times during recovery. All patients were assessed with the Wechsler Memory Scale-Revised at baseline (preoperatively) and 4 hours after the operation.
RESULTS: Seventy patients were enrolled in the study and randomly assigned to 1 of 2 groups: group D (sex, male/female, 23/12; mean [SEM] age, 32.53 [2.07] years; mean [SEM] weight, 73.03 [2.41] kg) or group M (sex, male/female, 21/14; mean [SEM] age, 34.43 [1.83] years; mean [SEM] weight, 67.90 [2.32] kg). All hemodynamic parameters (SAP, DAP, MAP, HR) were significantly higher in group M compared with group D from the onset of the surgery to discharge time (P < 0.05). Pain and sedation scores were similar in both groups, but the amount of PCA-administered rescue tramadol was significantly higher in group M (P = 0.001). A higher, though not statistically significant, prevalence of adverse events (ie, hypotension, bradycardia, and perioperative nausea and vomiting) were observed in group D. Postoperative logical verbal memory and digit span values were significantly higher in group D when compared with group M (P < 0.05). Postoperative digit span and visual reproduction scores were significantly higher than preoperative values in group D (P < 0.05). Postoperative personality functioning scores were significantly higher than preoperative values in group M (P < 0.05).
CONCLUSIONS: Based on VRS, Ramsay sedation scores, and surgeon and anesthesiologist satisfaction scores, dexmedetomidine or midazolam combined with tramadol PCA provided adequate analgesia and sedation in these adult patients undergoing septoplasty or endoscopic sinus surgery with MAC. A significantly larger amount of rescue tramadol was used by group M, suggesting that a better analgesic effect was achieved with dexmedetomidine.

Entities:  

Keywords:  cognitive function; dexmedetomidine; midazolam; sedoanalgesia

Year:  2007        PMID: 24678121      PMCID: PMC3965987          DOI: 10.1016/j.curtheres.2007.04.001

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN: 0011-393X


  22 in total

Review 1.  Alpha-2 adrenoceptor agonists: defining the role in clinical anesthesia.

Authors:  M Maze; W Tranquilli
Journal:  Anesthesiology       Date:  1991-03       Impact factor: 7.892

2.  The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery.

Authors:  P Talke; R Chen; B Thomas; A Aggarwall; A Gottlieb; P Thorborg; S Heard; A Cheung; S L Son; A Kallio
Journal:  Anesth Analg       Date:  2000-04       Impact factor: 5.108

3.  A comparison of patient-controlled sedation using either remifentanil or remifentanil-propofol for shock wave lithotripsy.

Authors:  H S Joo; W J Perks; M T Kataoka; L Errett; K Pace; R J Honey
Journal:  Anesth Analg       Date:  2001-11       Impact factor: 5.108

4.  Mapping receptors for alpha 2-agonists in the central nervous system.

Authors:  M J Kuhar; J R Unnerstall
Journal:  J Cardiovasc Pharmacol       Date:  1984       Impact factor: 3.105

Review 5.  Postoperative analgesia and sedation in the adult intensive care unit: a guide to drug selection.

Authors:  Linda L Liu; Michael A Gropper
Journal:  Drugs       Date:  2003       Impact factor: 9.546

6.  Effects of dexmedetomidine, a selective alpha 2-adrenoceptor agonist, on hemodynamic control mechanisms.

Authors:  A Kallio; M Scheinin; M Koulu; R Ponkilainen; H Ruskoaho; O Viinamäki; H Scheinin
Journal:  Clin Pharmacol Ther       Date:  1989-07       Impact factor: 6.875

7.  Dexmedetomidine in combination with morphine PCA provides superior analgesia for shockwave lithotripsy.

Authors:  Jamal A Alhashemi; Abdullah M Kaki
Journal:  Can J Anaesth       Date:  2004-04       Impact factor: 5.063

Review 8.  Tramadol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states.

Authors:  C R Lee; D McTavish; E M Sorkin
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

9.  Reversal of the sedative and sympatholytic effects of dexmedetomidine with a specific alpha2-adrenoceptor antagonist atipamezole: a pharmacodynamic and kinetic study in healthy volunteers.

Authors:  H Scheinin; R Aantaa; M Anttila; P Hakola; A Helminen; S Karhuvaara
Journal:  Anesthesiology       Date:  1998-09       Impact factor: 7.892

10.  Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate.

Authors:  J P Belleville; D S Ward; B C Bloor; M Maze
Journal:  Anesthesiology       Date:  1992-12       Impact factor: 7.892

View more
  17 in total

1.  Controlled hypotension with desflurane combined with esmolol or dexmedetomidine during tympanoplasty in adults: A double-blind, randomized, controlled trial.

Authors:  Iclal Ozdemir Kol; Kenan Kaygusuz; Altan Yildirim; Mansur Dogan; Sinan Gursoy; Evren Yucel; Caner Mimaroglu
Journal:  Curr Ther Res Clin Exp       Date:  2009-06

2.  Efficacy of Intranasal Dexmedetomidine for Conscious Sedation in Patients Undergoing Surgical Removal of Impacted Third Molar: A Double-Blind Split Mouth Study.

Authors:  Sujeeth Kumar Shetty; Garima Aggarwal
Journal:  J Maxillofac Oral Surg       Date:  2016-04-21

3.  Efficacy of dexmedetomidine on postoperative nausea and vomiting: a meta-analysis of randomized controlled trials.

Authors:  Xiao Liang; Miao Zhou; Jiao-Jiao Feng; Liang Wu; Shang-Ping Fang; Xin-Yu Ge; Hai-Jing Sun; Peng-Cheng Ren; Xin Lv
Journal:  Int J Clin Exp Med       Date:  2015-06-15

4.  Dexmedetomidine versus midazolam for sedation during endoscopy: A meta-analysis.

Authors:  Fan Zhang; Hao-Rui Sun; Ze-Bing Zheng; Ren Liao; Jin Liu
Journal:  Exp Ther Med       Date:  2016-03-24       Impact factor: 2.447

5.  Efficacy of dexmedetomidine on postoperative nausea and vomiting: a meta-analysis of randomized controlled trials.

Authors:  Xiao Liang; Miao Zhou; Jiao-Jiao Feng; Liang Wu; Shang-Ping Fang; Xin-Yu Ge; Hai-Jing Sun; Peng-Cheng Ren; Xin Lv
Journal:  Int J Clin Exp Med       Date:  2015-08-15

6.  Intranasal Dexmedetomidine on Stress Hormones, Inflammatory Markers, and Postoperative Analgesia after Functional Endoscopic Sinus Surgery.

Authors:  Chaoliang Tang; Xiang Huang; Fang Kang; Xiaoqing Chai; Song Wang; Guobing Yin; Hongtao Wang; Juan Li
Journal:  Mediators Inflamm       Date:  2015-06-25       Impact factor: 4.711

7.  Induced hypotension for functional endoscopic sinus surgery: A comparative study of dexmedetomidine versus esmolol.

Authors:  Tarek Shams; Nahla S El Bahnasawe; Mohamed Abu-Samra; Ragaa El-Masry
Journal:  Saudi J Anaesth       Date:  2013-04

8.  A prospective randomized double-blind study comparing dexmedetomidine vs. combination of midazolam-fentanyl for tympanoplasty surgery under monitored anesthesia care.

Authors:  Devangi A Parikh; Sagar N Kolli; Hemangi S Karnik; Smita S Lele; Bharati A Tendolkar
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2013-04

9.  A double blind, randomized, controlled trial to study the effect of dexmedetomidine on hemodynamic and recovery responses during tracheal extubation.

Authors:  Barkha Bindu; Surender Pasupuleti; Upender P Gowd; Venkateshwarlu Gorre; Radha R Murthy; M Bhanu Laxmi
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2013-04

10.  Dexmedetomidine versus midazolam for conscious sedation in endoscopic retrograde cholangiopancreatography: An open-label randomised controlled trial.

Authors:  Priyanka Sethi; Sadik Mohammed; Pradeep Kumar Bhatia; Neeraj Gupta
Journal:  Indian J Anaesth       Date:  2014-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.